A potentially functional polymorphism in ABCG2 predicts clinical outcome of non-small cell lung cancer in a Chinese population

被引：10

作者：

Sun, J. ^{[1
]}

Zhu, M. ^{[1
]}

Shen, W. ^{[1
]}

Wang, C. ^{[1
]}

Dai, J. ^{[1
]}

Xu, L. ^{[2
]}

Jin, G. ^{[1
,3
]}

Hu, Z. ^{[1
,3
]}

Ma, H. ^{[1
,3
]}

Shen, H. ^{[1
,3
]}

机构：

[1] Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Collaborat Innovat Ctr Canc Med, 101 Longmian Rd, Nanjing 211166, Jiangsu, Peoples R China

[2] Nanjing Med Univ, Affiliated Canc Hosp, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Mol & Translat Canc Res, Nanjing, Jiangsu, Peoples R China

[3] Nanjing Med Univ, Collaborat Innovat Ctr Canc Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing, Jiangsu, Peoples R China

来源：

PHARMACOGENOMICS JOURNAL | 2017年 / 17卷 / 03期

基金：

中国国家自然科学基金;

关键词：

RESISTANCE PROTEIN; STEM-CELL; PROGNOSTIC MARKER; CD133; EXPRESSION; SIDE-POPULATION; CHEMOTHERAPY; TRANSPORTER; SURVIVAL; GENE; CARCINOMA;

D O I：

10.1038/tpj.2016.2

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

ABCG2, CD133 and CD117 are pivotal markers of cancer stem cell, which are involved in carcinogenesis and cancer progression. The expression of these genes has been reported to be associated with the development and progression of many cancers, including non-small cell lung cancer (NSCLC). We selected and genotyped 9 potentially functional single-nucleotide polymorphisms in the 3 genes in a clinical cohort of 1001 NSCLC patients in a Chinese population. We found that variant genotypes of ABCG2 rs3114020 were associated with a significantly increased risk of death for NSCLC (additive model: adjusted hazard ratio = 1.25, 95% confidence intervals = 1.10-1.42, P < 0.001). Further stepwise regression analysis suggested that rs3114020 was an independent risk factor for the prognosis of NSCLC. Besides, histology interacted with the genetic effect of rs3114020 in relation to NSCLC survival in the interaction analysis. Our findings show that ABCG2 rs3114020 might be one of the candidate biomarkers for NSCLC survival in this Chinese population, especially among patients with adenocarcinoma.

引用

页码：280 / 285

页数：6

共 44 条

[1]

[Anonymous], 2018, ANTI-CANCER DRUG, DOI [DOI 10.3322/caac.20115, DOI 10.1097/CAD.0000000000000617]

[2] Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment [J].

Bertolini, Giulia ;

Roz, Luca ;

Perego, Paola ;

Tortoreto, Monica ;

Fontanella, Enrico ;

Gatti, Laura ;

Pratesi, Graziella ;

Fabbri, Alessandra ;

Andriani, Francesca ;

Tinelli, Stella ;

Roz, Elena ;

Caserini, Roberto ;

Lo Vullo, Salvatore ;

Camerini, Tiziana ;

Mariani, Luigi ;

Delia, Domenico ;

Calabro, Elisa ;

Pastorino, Ugo ;

Sozzi, Gabriella .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (38) :16281-16286

[3] A comprehensive study of polymorphisms in the ABCB1, ABCC2, ABCG2, NR1I2 genes and lymphoma risk [J].

Campa, Daniele ;

Butterbach, Katja ;

Slager, Susan L. ;

Skibola, Christine F. ;

de Sanjose, Silvia ;

Benavente, Yolanda ;

Becker, Nikolaus ;

Foretova, Lenka ;

Maynadie, Marc ;

Cocco, Pierluigi ;

Staines, Anthony ;

Kaaks, Rudolf ;

Boffetta, Paolo ;

Brennan, Paul ;

Conde, Lucia ;

Bracci, Paige M. ;

Caporaso, Neil E. ;

Strom, Sara S. ;

Camp, Nicola J. ;

Cerhan, James R. ;

Canzian, Federico ;

Nieters, Alexandra .

INTERNATIONAL JOURNAL OF CANCER, 2012, 131 (04) :803-812

[4] Core Labeling: A New Way to Compress Transitive Closure [J].

Chen, Yangjun ;

Chen, Yibin .

SITIS 2008: 4TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY AND INTERNET BASED SYSTEMS, PROCEEDINGS, 2008, :3-10

[5] A microRNA-135a/b binding polymorphism in CD133 confers decreased risk and favorable prognosis of lung cancer in Chinese by reducing CD133 expression [J].

Cheng, Mei ;

Yang, Lei ;

Yang, Rongrong ;

Yang, Xiaorong ;

Deng, Jieqiong ;

Yu, Bolan ;

Huang, Dongsheng ;

Zhang, Shuxu ;

Wang, Hui ;

Qiu, Fuman ;

Zhou, Yifeng ;

Lu, Jiachun .

CARCINOGENESIS, 2013, 34 (10) :2292-2299

[6] Biology of gastrointestinal stromal tumors [J].

Corless, CL ;

Fletcher, JA ;

Heinrich, MC .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (18) :3813-3825

[7] CD133 Expression Defines a Tumor Initiating Cell Population in Primary Human Ovarian Cancer [J].

Curley, Michael D. ;

Therrien, Vanessa A. ;

Cummings, Christine L. ;

Sergent, Petra A. ;

Koulouris, Carolyn R. ;

Friel, Anne M. ;

Roberts, Drucilla J. ;

Seiden, Michael V. ;

Scadden, David T. ;

Rueda, Bo R. ;

Foster, Rosemary .

STEM CELLS, 2009, 27 (12) :2875-2883

[8] Genome-wide scan for familial nasopharyngeal carcinoma reveals evidence of linkage to chromosome 4 [J].

Feng, BJ ;

Huang, W ;

Shugart, YY ;

Lee, MK ;

Zhang, F ;

Xia, JC ;

Wang, HY ;

Huang, TB ;

Jian, SW ;

Huang, P ;

Feng, QS ;

Huang, LX ;

Yu, XJ ;

Li, D ;

Chen, LZ ;

Jia, WH ;

Fang, Y ;

Huang, HM ;

Zhu, JL ;

Liu, XM ;

Zhao, Y ;

Liu, WQ ;

Deng, MQ ;

Hu, WH ;

Wu, SX ;

Mo, HY ;

Hong, MF ;

King, MC ;

Chen, Z ;

Zeng, YX .

NATURE GENETICS, 2002, 31 (04) :395-399

[9] Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer [J].

Gandara, D ;

Narayan, S ;

Lara, PN ;

Goldberg, Z ;

Davies, A ;

Lau, DHM ;

Mack, P ;

Gumerlock, P ;

Vijayakumar, S .

CLINICAL CANCER RESEARCH, 2005, 11 (13) :5057S-5062S

[10]

Gottschling S, 2013, ANTICANCER RES, V33, P981

← 1 2 3 4 5 →